These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3685870)

  • 1. Normal activity of C27-steroid 26-hydroxylase in cultured sitosterolaemia fibroblasts.
    Boberg KM; Björkhem I; Skrede S
    Scand J Clin Lab Invest; 1987 Nov; 47(7):701-4. PubMed ID: 3685870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Kvittingen EA; Buchmann MS; Lie SO; East C; Grundy S
    J Clin Invest; 1986 Sep; 78(3):729-35. PubMed ID: 3745434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced C27-steroid 26-hydroxylase activity in heterozygotes for cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Kvittingen EA; East C; Grundy S; Skrede S
    Scand J Clin Lab Invest; 1988 Sep; 48(5):425-9. PubMed ID: 3206189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.
    Oftebro H; Björkhem I; Skrede S; Schreiner A; Pederson JI
    J Clin Invest; 1980 Jun; 65(6):1418-30. PubMed ID: 7410549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX).
    Kim KS; Kubota S; Kuriyama M; Fujiyama J; Björkhem I; Eggertsen G; Seyama Y
    J Lipid Res; 1994 Jun; 35(6):1031-9. PubMed ID: 7915755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
    J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased (23R)-hydroxylase activity in patients suffering from cerebrotendinous xanthomatosis, resulting in (23R)-hydroxylation of bile acids.
    Koopman BJ; Wolthers BG; Van der Molen JC; Nagel GT; Rutgers H; Strijtveen B; Kaptein B
    Biochim Biophys Acta; 1986 Oct; 883(3):585-92. PubMed ID: 3756224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
    Setoguchi T; Salen G; Tint GS; Mosbach EH
    J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
    J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.
    Javitt NB; Kok E; Cohen B; Burstein S
    J Lipid Res; 1982 May; 23(4):627-30. PubMed ID: 7097127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase.
    Shefer S; Salen G; Nguyen L; Batta AK; Packin V; Tint GS; Hauser S
    J Clin Invest; 1988 Dec; 82(6):1833-9. PubMed ID: 3143743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study.
    Björkhem I; Fausa O; Hopen G; Oftebro H; Pedersen JI; Skrede S
    J Clin Invest; 1983 Jan; 71(1):142-8. PubMed ID: 6848555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A paradigm to elucidate a congenital disease, cerebrotendinous xanthomatosis].
    Okuda K; Setoguchi T
    Tanpakushitsu Kakusan Koso; 1994 Sep; 39(12):2102-12. PubMed ID: 7938607
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative analysis of the mitochondrial cytochrome P-450-linked monooxygenase system: NADPH-hepatoredoxin reductase, hepatoredoxin, and cytochrome P-450s27 in livers of patients with cerebrotendinous xanthomatosis.
    Miki H; Takeuchi H; Yamada A; Nishioka M; Matsuzawa Y; Hamamoto I; Hiwatashi A; Ichikawa Y
    Clin Chim Acta; 1986 Nov; 160(3):255-63. PubMed ID: 3791635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cases of familial cerebrotendinous xanthomatosis--intrahepatic enzyme assay and therapeutic trial with chenodeoxycholic acid].
    Orimo S; Kobayashi T; Furukawa T; Tsukagoshi H; Kano I
    Rinsho Shinkeigaku; 1984 Jan; 24(1):38-44. PubMed ID: 6467736
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes.
    Furster C; Wikvall K
    Biochim Biophys Acta; 1999 Jan; 1437(1):46-52. PubMed ID: 9931427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
    Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
    J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of a Japanese cerebrotendinous xanthomatosis family: identification of a novel mutation in the adrenodoxin binding region of the CYP 27 gene.
    Chen W; Kubota S; Nishimura Y; Nozaki S; Yamashita S; Nakagawa T; Kameda-Takemura K; Menju M; Matsuzawa Y; Björkhem I; Eggertsen G; Seyama Y
    Biochim Biophys Acta; 1996 Nov; 1317(2):119-26. PubMed ID: 8950197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [27-Hydroxylase deficiency (cerebrotendinous xanthomatosis)].
    Miyamoto K; Setoguchi T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):285-8. PubMed ID: 9645063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.